Christopher von Seggern is CCO at Xenon Pharmaceuticals Inc. (XENE). They have made 1 open-market trade across 1 company since 2021, most recently 2021-12-06.
CIK 0001821192
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $98K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XENE | 4,000 | $134K |
Shares reported on the most recent Form 4, priced at the 2021-12-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XENE | BUY | 2021-12-06 | 2021-12-07 | $24.40 | $98K | +5.8% | +16.9% | +13.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.